Fundz

Vista Gen Therapeutics, Inc. reported raising $1.04 Million in an initial SEC Form D filing, from an offering of $1.04 Million

PUBLIC · VTGNAug 22, 2017

Amount Raised

$1.04 Million

$1.04 Million sold, per SEC Form D (first sale Aug 22, 2017)

Round Type

Venture

South San FranciscoBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Quick answer

VistaGen raised $1.04 Million in a funding round, dated August 22, 2017. VistaGen is based in South San Francisco, California, United States.

How much did VistaGen raise?
VistaGen raised $1.04 Million in a funding round on August 22, 2017.
What does VistaGen do?
Vistagen is a late clinical-stage biopharmaceutical company headquartered in South San Francisco, CA, developing and commercializing a new class of intranasal product candidates called pherines.
Where is VistaGen based and how big is it?
VistaGen is based in South San Francisco, California, United States.
Who are the decision-makers at VistaGen?
Fundz holds 1 contact at VistaGen. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as VistaGen that raised within 45 days of this round, from Fundz verified event records.

Who to call at VistaGen, and when

A new round usually means VistaGen is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day VistaGen raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at VistaGen, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at VistaGen. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

VistaGen

Location

343 Allerton Avenue

South San Francisco, California, United States

About

Vistagen is a late clinical-stage biopharmaceutical company headquartered in South San Francisco, CA, developing and commercializing a new class of intranasal product candidates called pherines. Leveraging advanced insights into nose-to-brain neurocircuitry, Vistagen designs pherines to selectively activate peripheral nasal chemosensory receptors and rapidly trigger olfactory bulb–to-brain pathways that influence behavior and autonomic nervous system activity. Because they are engineered to work without entering the bloodstream or brain, pherines have the potential to offer safer therapeutic alternatives to existing pharmacological treatments if successfully developed and approved.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment VistaGen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts24 people are listed at VistaGen. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for VistaGen's next move

See what Strategic adds

VistaGen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.